MCX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - McCormick & Company Inc

Watchlist Manager

Watchlist

Price: 39.4 EUR -8.27%

Market Cap: €10.6B

M	McCormick & Company Inc F:MCX	US
T	Takeda Pharmaceutical Co Ltd SWB:TKD	JP

Profitability Summary

McCormick & Company Inc's profitability score is 58/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

38%

Gross Margin is Increasing

37% > 39%

Healthy Operating Margin

16%

Sustainable 3Y Average Operating Margin

16%

Operating Margin is Increasing

15% > 16%

Healthy Net Margin

22%

Sustainable 3Y Average Net Margin

13%

Net Margin is Increasing

10% > 22%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

12% > 14%

Exceptional ROE

26%

Positive 3Y Average ROE

View All

Hide

Collapse

58 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.